The Western brown snake Pseudonaja affinis (dugite), common to the Perth area of Western Australia, possesses one of the most lethal venoms in the world. Little is known, however, about the toxic protein constituents of the venom, other than those causing coagulopathic and procoagulant effects. The current study was therefore undertaken in order to identify other protein constituents and activities present. Crude venom induced a contraction in rat tracheal preparations through phospholipase A 2 (PLA 2 ) activity, as shown by the complete and partial inhibition of contraction by PLA 2 inhibitors 4-bromophenacyl bromide and quinacrine. Further, a reduced degree of smooth muscle contraction in the presence of the leukotriene receptor antagonist SKF104353 suggested that this effect was mediated by leukotriene metabolites. The venom-induced contraction did not reoccur upon a second administration of the venom, despite the muscle retaining its contractile function and appearing histologically undamaged. Chromatographic separation of the protein constituents of the venom showed that PLA 2 activity was associated with all protein fractions. A low-molecular-weight component of the venom was further investigated through N-terminal sequencing and found to possess high identity to the short-chain ␣-neurotoxin family of toxins. Venom activity on cultured rat cardiac myocytes and cultured cortical neurons was also examined. The crude venom was found to temporarily inhibit the beating of the cardiac myocytes, after which the beating resumed erratically. Cortical neurons, however, were irreversibly affected, showing concentration-dependent cell death. 
Snake venom components have been studied extensively for the past 40 years in an effort to better understand their toxic effects as well as to identify protein components with therapeutic potential. The venom toxins mediate a range of physiological effects such as hemorrhage (Bonta et al., 1970) , coagulation (Herzig et al., 1970) , paralysis (Campbell, 1975) , cardiac arrest, respiratory failure (Sutherland et al., 1981) , as well as tissue necrosis (Smith and Figge, 1991) . Some of the most lethal venoms are produced by the elapid snakes of Australia, with potent coagulopathic, phospholipase, and neurotoxic activities. Of these, only a subset of the protein components from the venom of the eastern brown snake, Pseudonaja textilis, has been investigated in any detail. Identified proteins include the prothrombin activator textarin (Stocker et al., 1994) , the long-chain (pseudonaja toxin b) and short-chain (Pt-sntx) ␣-neurotoxins (Tyler et al., 1987; Gong et al., 1999) and textilotoxin, the most potent neurotoxic PLA 2 yet discovered (Pearson et al., 1993; Su et al., 1983) .
In contrast, very little is known about the protein constituents of the venom from the Western cousin of P. textilis, Pseudonaja affinis (also known as dugite). The characteristic feature of dugite envenomation in humans is hemorrhage due to a consumptive coagulopathy; hence, studies characterizing the venom components of the dugite have been restricted to the coagulopathic effects (Sprivulis et al., 1996; Jelinek et al., 1991) . Consumptive coagulopathy is mainly attributed to an 80-kDa serine protease, found to be conserved over the genus Pseudonaja (Williams et al., 1994) . The additional clinical effects following severe dugite envenomation, such as cerebral hemorrhage, kidney damage, paralysis, cardiac arrhythmias, and even cardiac arrest, though less common, would suggest the presence of potent enzymes and toxins in the venom that have yet to be identified (Williams et al., 1994; White, 1987; Jelinek et al., 1991) .
In an effort to further understand the properties of the venom, several biological assays have been employed in the current study, including the use of neurons and myocytes in culture, as well as nerve/muscle preparations in tension-recording experiments to identify the activity of toxins targeting these cell and tissue types. Identification of the toxins present in dugite venom may explain the occurrence of paralysis and cardiac arrest in victims of severe dugite envenomation.
MATERIALS AND METHODS

Materials
Lyophilized venom from P. affinis was purchased from Venom Supplies (Tanunda, South Australia). Venom (200 mg) was suspended in 10 ml of 0.1 M phosphate-buffered saline (PBS), centrifuged at 7500g for 10 min, and the supernatant stored at Ϫ20°C. All reagents, unless otherwise indicated, were of analytical grade and purchased from Sigma Chemical Co. (St. Louis, MO).
Isolation and Purification of Active Components from Crude Venom
Venom components were separated by gel-filtration chromatography using a Superose-12 column (Pharmacia, NJ). Separated fractions, eluted with 0.1 M PBS (pH 7.4) at a flow rate of 0.5 ml/min and detected at 280 nm, were concentrated using centrifugal concentrators (1-kDa cutoff) for 4 h at 7500g. Fractions were electrophoresed on a 18% Tris-Tricine SDS polyacrylamide gel (1.8 mm) for 5 h at 80 V and visualized with Coomassie brilliant blue stain. Fraction 3 (containing the lowest molecular weight proteins) was further purified by reverse-phase HPLC on a Vydac C-18 column (5 m, 4.6 ϫ 250 mm; Hesperia, CA) equilibrated in 95% solution A (0.1% TFA and water) and 5% solution B (90% CH 3 CN, 0.1% TFA in water) for 10 min. A gradient from 5 to 100% solution B over 29 min with a flow rate of 1 ml/min was used, and the venom components were monitored at 220 nm. The collected fractions were lyophilized overnight and stored at Ϫ20°C, with the main purified component submitted for amino-terminal sequencing (Protein Facility, Western Australia).
Peptide Sequencing and Analysis
N-terminal sequencing by automatic Edman degradation was conducted with 1-10 pmol of sample using a ABI476A protein sequencer (Applied Biosystems, Foster City, CA). The amino acid sequence of the first 40 residues of P. affinis protein was compared to other sequences using NCBI BLAST (Altschul et al., 1990) .
Tension-Recording Studies in Rat Isolated Trachea
(i) Crude venom. To study the effect of crude dugite venom on tracheal muscle preparations, 8-to 10-week-old male Wistar SPF rats (Animal Resource Centre, Western Australia) were anesthetized with sodium pentobarbital (200 mg/kg, intraperitoneal) and sacrificed, and the trachea was removed and sectioned into rings of 2 mm length. Tracheal sections were mounted onto stainless-steel hooks attached to force displacement transducers (Grass FT03C). A resting tension of 500 mg was applied. The tracheas were immersed in Sigmacoate-treated organ baths containing 2 mL Krebs bicarbonate solution (6.9 g/L NaCl, 2 g/L glucose, 2.1 g/L NaHCO 3 , 5 mL of 80 g/L KCl, 2 mL of 70 g/L MgSO 4 , 2 mL of 70 g/L KH 2 PO 4 , 2 mL of 40% CaCl 2 ) with indomethacin (3 M bath concentration in 0.9% NaCI) bubbled with carbogen (95% O 2 and 5% CO 2 ) at 37°C. Changes in smooth muscle tension were recorded using a Grass Polygraph (Model 7B). After equilibration (1 h), tracheal contractile function was tested by the addition of a supramaximal, bolus dose of carbachol (30 M). Following a 20-min rest and washout period, tissues were exposed to cumulatively added concentrations of carbachol (30 nM-30 M), washed for a further 20 min, and then exposed to crude dugite venom (190 g/mL of venom protein) for 15-30 min. The muscle was then washed and rested for a further 30 min, and a second dose-response curve to carbachol was completed.
(ii) Crude venom and phospholipase antagonists. In some experiments, preparations were incubated with the PLA 2 inhibitors 4-bromophenacyl bromide (4-BPB, 180 M for 30 min) or quinacrine (10 M, for 30 min), or the leukotriene receptor antagonist SKF104353 (10 M, for 15 min) prior to venom addition (190 g/mL). Venom-induced contractions were expressed as a percentage of the response observed to 30 M carbachol obtained at the beginning of the experiment.
(iii) Venom fractions. Response of trachea to dugite venom fractions purified by gel filtration chromatography was determined with venom fraction protein concentrations of 500 g/mL (bath concentration). The crude and purified venom protein content was determined by the BCA assay (Pierce Chemicals, Rockford, IL).
Statistical Analysis
All data are presented as the means Ϯ SEM and group data compared using analysis of variance (one-way ANOVA), with a P value Ͻ 0.05 considered significant.
Light Microscopic Examination of Venom-Treated Trachea
Tracheal segments from organ bath experiments were processed in preparation for paraffin wax sectioning (Bancroft and Stevens; 1977) . Sections of 5 m thickness were mounted onto glass slides, stained with Harris's hematoxylin and eosin (H&E), and viewed at 200ϫ magnification.
Electron Microscopic Examination of Venom-Treated Trachea
Following organ bath experiments, tracheal segments were removed and placed in 2% glutaraldehyde for 4 h, followed by cacodylate buffer. Tissues were postfixed with osmium tetroxide, and thin sections (50 nm) prepared and stained as described by Robertson et al. (2000) . The transmission electron microscope used was Phillips 410LS at 4800ϫ magnification.
Effects of Crude Venom on Spontaneously Beating Cardiac Myocytes
Spontaneously beating ventricular cardiomyocytes were prepared from neonatal rat hearts as described in Bogoyevitch et al. (1995) . The cells were treated with crude venom (200, 100, 20, 2, and 0.2 g/mL protein concentration) 2 days after plating and incubation at 37°C. The beating pattern and morphology were monitored within a 24-h period at 200ϫ magnification.
Effects of Crude Venom on Neurons
Rat fetal cortical neurons were isolated and cultured according to Namgung et al. (2000) . Neurons were treated with varying amounts of crude venom (200, 100, 20, 2, and 0.2 g/mL protein concentration) 2 days after plating following a change of culture media. Their morphology was monitored at 200ϫ magnification in a 24-h period.
RESULTS
Crude Dugite Venom Induced Contraction in Rat Isolated Trachea
Crude dugite venom (190 g/mL) induced a marked contractile response in rat isolated tracheal preparations (Fig. 1 ). The magnitude of the peak response was 75 Ϯ 5% of the maximum carbachol-induced response. The peak was observed approximately 3 min after venom addition, and was maintained for at least 15-30 min (n ϭ 10). Venom-induced contractions were reversed by washout, but did not reoccur upon administration of a second venom dose to the same tissue (n ϭ 3). Venom did not impair tissue contractile responses to carbachol (EC 50 before venom ϭ 0.49 M (95% confidence limits, 0.42-0.60 M, n ϭ 13); EC 50 after venom ϭ 0.35 M (95% confidence limits, 0.30 -0.40 M, n ϭ 13)).
Contractile Response with PLA 2 Antagonists
Both quinacrine and 4-BPB significantly inhibited venominduced contractions ( Fig. 2 ; one-way ANOVA, P Ͻ 0.05). Quinacrine (10 M) inhibited venom-induced responses by more than half (approximately 40% of the dugite-induced response), whereas 4-BPB (180 M) caused complete abolition of the response (n ϭ 3). These results indicate that PLA 2 proteins present in the venom were responsible for the contractions, and likely to act via downstream products of PLA 2 activity such as leukotrienes. To assess the possible role of leukotrienes in venom-induced contractions, tracheal preparations were incubated with a leukotriene receptor antagonist SKF104353 prior to venom addition (n ϭ 3). SKF104353 reduced the venom-induced contractions to approximately 39% of the dugite-induced response, (one way ANOVA, P Ͻ 0.05), suggesting that leukotrienes are involved to some extent in the venom contractile response (Fig. 2) .
Examination of Venom Fractions
In order to further characterize the proteins present in venom, crude dugite venom (1 mg/mL) was fractionated using gel-filtration chromatography, and fractions were examined by gel electrophoresis and tested for their ability to cause rat tracheal contractions. Six main fractions were collected (Fig.  3A) . The gel electrophoretogram (Fig. 3B) shows that the venom fractions contain a wide range of protein components, ranging in size from 200 to 6 kDa, with the high-molecularweight proteins confined to the earliest eluting fractions 1a and 1b. Fractions 2a, 2b, and 3 contained protein components of between 22 and 6 kDa, with species of approximately 20, 13, and 6 kDa predominating. Fraction 4 did not give rise to any protein bands, and is likely to represent a low-molecularweight non protein component in the venom. Since fractions 1a and 1b contained common components, as did fractions 2a and 2b, these were pooled for measurement of rat tracheal contractility and are referred to in these studies as fractions 1 and 2, respectively.
Venom fractions 1, 2, and 3 (500 g/mL) all induced a tracheal muscle contractile response. These were 31 Ϯ 4, 41 Ϯ 5, and 49 Ϯ 10% of the carbachol-induced response, respectively (one-way ANOVA, P Ͻ 0.05), representing a significant response compared to the crude venom response of 75 Ϯ 5% ( Fig. 4; n ϭ 3 ).
Light and Electron Microscopic Analysis of Venom-Treated Tracheal Segments
Following treatment with crude dugite venom, the tracheal segments were analyzed for evidence of tissue damage. Light microscopic analysis revealed that tracheal segments treated with crude venom (190 g/mL venom concentration for 30 min at 37°C) exhibited complete degradation of the epithelial layer (E). This was in contrast to control tracheal segments from organ baths that were not exposed to the dugite venom (Fig. 5A untreated trachea, Fig. 5B venom-treated trachea) . Muscle (M) and collagen (C) appeared to be unaffected by the addition of venom. Closer inspection by transmission electron microscopy verified the intact state of smooth muscle cells and collagen. However, a spatial separation between muscle and collagen fibers was observed, suggesting an edematous response to venom exposure (Fig. 5C untreated trachea, Fig 5D  venom-treated trachea) .
Venom Toxicity Assay with Cultured Cardiac Myocytes
Crude dugite venom was applied to cultures of spontaneously beating cardiac myocytes in order to observe the venom effects. Application of the venom was found to alter the beating pattern of normal healthy cardiac myocytes, which beat strongly in a uniform manner (n ϭ 6). Venom (200 and 100
FIG. 2.
Inhibition of dugite-induced contraction of rat trachea by eicosanoid antagonists. The PLA 2 inhibitor quinacrine (10 M) partially abolished venom-induced contractility (30 Ϯ 2% of carbachol-induced contraction, P Ͻ 0.05) when compared to the control response (75 Ϯ 5% of carbachol-inducedcontraction, P Ͻ 0.05), whereas the PLA 2 inhibitor 4-BPB (180 mM) completely abolished the contraction. SKF104353 (100 M) also partially abolished venom contraction (29 Ϯ 6% of carbachol induced contraction; *P Ͻ 0.05).
FIG. 1.
Dugite venom causes a contraction of rat trachea. Venom (190 g/mL protein concentration) was added to a tracheal segment (resting tension 500 mg), resulting in a significant contraction (75 Ϯ 5% of that induced by 30 M carbachol). Venom did not reduce tissue viability since carbachol-induced contractions obtained after venom administration were not attenuated. g/mL protein concentration) caused myocyte beating to cease for approximately 2 min immediately after addition. Beating resumed in an erratic fashion characterized by patches of hypercontracting cells and patches of cells that were beating very slowly. A strong, uniform beating pattern was observed to resume approximately 24 h after venom administration. Lower venom concentrations (20, 2, and 0.2 g/mL), however, did not mediate any perturbations of the myocyte beating pattern. Morphologically, the myocytes exposed to varying concentrations of venom retained their shape, with no evidence of necrosis or cellular damage.
Venom Toxicity Assay with Cultured Cortical Neurons
Toxicity assays were carried out to observe the in vitro effect of dugite venom on cortical neurons. The effect of crude venom 30 min, 60 min, and 24 h after treatment is illustrated in Fig. 6 . Venom administered at 200 g/mL resulted in partial degradation of the nerve cell body and axons after 30 min. After 60 min, degradation was severe and complete, with the appearance of predominantly particulate matter. This did not further increase after 24 h. A dose dependency of this effect was observed, with lower doses (100, 20, 2, and 0.2 g/mL) being slower to induce degradation, and not showing as severe damage after 24 h.
Amino-Terminal Sequencing
It was of interest to determine the identity of the lowmolecular-weight protein(s) present in the venom. For this reason, fraction 3, already partially purified by gel-filtration chromatography (Fig. 3) , underwent further purification by reverse-phase HPLC. One main fraction was eluted, and this was subjected to amino-terminal sequencing. A total of 40 residues were successfully sequenced, and this partial sequence data were compared to other snake amino acid sequences using BLAST (Altschul et al., 1990 ; Fig. 7 ). The dugite venom sequence was found to possess considerable sequence identity to elapid short chain ␣-neurotoxins, particularly to the P. textilis neurotoxins. The P. textilis short-chain ␣-neurotoxin isoforms (Pt-sntx) were found to be 77% (isoform 1), 80% (isoform 2), 82% (isoform 3), 74% (isoform 5), 72% (isoform 6), and 80% (isoform 7) identical to the P. affinis 40 amino acid sequence, respectively. Other short chain ␣-neurotoxins showed lower identity to the dugite sequence: Pseudechis australis (Pa a) 30%, Acanthopis antarcticus (Aa c) 27%, Naja nigricollis (Toxin ␣) 35%, Naja mossambica mossambica (Nm III) 35%, Laticauda semifasciata (Ls Ec) 30%, and Dendroaspis polylepis (Dp a) 30%.
DISCUSSION
The current investigation was undertaken in order to provide a more comprehensive study of the nature of toxin components in dugite venom. The results presented here have identified for the first time the presence of PLA 2 and a short-chain ␣-neu- rotoxin in dugite venom. Furthermore, the activity of venom components mediating neuron death and perturbations of myocyte beating has been reported.
PLA 2 in snake venoms function to hydrolyze membrane phospholipids, liberating fatty acids and lysophosphoglycerides. While these enzymes have an important digestive function, displaying considerable homology to mammalian pancreatic PLA 2 , they have also evolved to possess a wide range of pharmacological functions including neurotoxicity (Chang and Lee, 1963) , myotoxicity (Mebs and Ownby, 1990) , induction or inhibition of platelet aggregation (Marsh, 1994) , and cardiotoxicity , and thus also play a role in prey capture. In the current study, the presence of PLA 2 in dugite venom was shown to induce contractions of tracheal smooth muscle. The venom-induced muscle contraction was completely inhibited in the presence of the PLA 2 inhibitor 4-BPB, and partially abolished in the presence of quinacrine. Similar PLA 2 activity has also been identified in the venom of the taipans O. microlepidotus (Bell et al., 1998) and O. scutellatus (Crachi et al., 1999) , causing contractions of guinea pig ileum smooth muscle. Muscle contraction did not occur upon a second administration of dugite venom, and this has also been previously observed in other snake species (Bell et al., 1998; Ohara et al., 1995) . In the case of administration of Vipera ammodytes venom, a reduced secondary contraction of the ileum was reported (Sket and Gubensek, 1976) .
Despite the absence of a second muscle contraction, the muscle itself was not damaged, as demonstrated by the consistency of the carbachol response before and after venom application. Furthermore, histopathological examination by light microscopy of the venom-treated tracheal segment verified the intact state of the tracheal smooth muscle. Thus, tracheal myonecrosis mediated by PLA 2 does not appear to be a feature of dugite envenomation. Complete eradication of the epithelial layer, however, was observed, a finding consistent with the epithelial damage observed with B. asper envenomation (Rucavado et al., 1998) .
Muscle contraction due to snake venom PLA 2 is thought to occur as a direct result of lipase activity. PLA 2 activity results in arachidonic acid release from membrane phospholipids (Kini and Evans, 1989) . Arachidonic acid itself mediates the activation of the eicosanoid pathway and the subsequent generation of cyclooxygenase metabolites, such as thromboxanes and prostaglandins, and 5-lipoxygenase metabolites, such as leukotrienes (Kaiser et al., 1990 ). In the current contractile studies, the cyclooxygenase inhibitor indomethacin was present; therefore, the observed contraction was not due to cyclooxygenase metabolites. Application of the leukotriene receptor antagonist SKF104353 resulted in a reduced tracheal contraction, suggesting leukotrienes were involved in tracheal contractility.
Induction of edema through PLA 2 activity, observed for Bothrops (Soares et al., 2000; de Faria et al., 2001) and Naja naja atra (Zhang and Gopalakrishnakone, 1999) venoms, is thought to be the result of eicosanoid generation of leukotrienes and prostaglandins, leading to inflammation and subsequent increased vascular permeability, and thus edema (Lloret and Moreno, 1993; Chiu et al., 1989) . In the case of dugite venom, generation of leukotrienes from PLA 2 hydrolysis is thought to underlie the observed edema.
The presence of a range of PLA 2 species is consistent with the studies of dugite venom fractions. Fractionation of the venom by size-exclusion chromatography and gel electrophoresis showed that, while a number of protein species are present, a significant proportion were of approximately 13 kDa, the expected size for PLA 2 (Grieg-Fry, 1999) . In addition, all protein-containing fractions induced muscle contraction, suggesting the presence of PLA 2 in all three fractions, although this was not confirmed using PLA 2 inhibitors.
In a novel assay, the dugite venom was found to temporarily halt the beating of cardiac myocytes in culture, after which beating resumed irregularly. Cardiac arrhythmias are a phenomenon that has been observed in victims of envenomation by the cobra (Wang et al., 1997) and taipan (Fantini et al., 1996) , as well as bee (Okamoto et al., 1995) and spider (Pascarel et al., 1997) venoms, but have not previously been reported for elapid venom. While further research is required to determine the basis of this effect, it may involve the modulation of Ca 2ϩ flux in the cells. Cobra toxin was found to increase cellular contraction, and taipan toxin decrease contraction by elevating calcium influx into the cells through specific or nonspecific Ca 2ϩ channels or Na ϩ ϪCa 2ϩ exchangers, as well as impaired sequestration of Ca 2ϩ in the sarcoplasmic reticulum (Fantini et al., 1996; Wang et al., 1997) . It is possible that such Ca 2ϩ flux is effected through PLA 2 activity. PLA 2 metabolites have been shown to mediate arrhythmias by the release of free fatty acids through the modulation of sodium and calcium currents (Kang and Leaf, 2000; Pi and Walker, 2000; Fantini et al., 1996) .
While the cardiomyocytes were only temporarily affected by the venom, cortical neurons in culture underwent a concentration-dependent cell death. The rapid destruction of the cell body is consistent with PLA 2 activity. Studies of bee venom PLA 2 (Kolko et al., 1996; Clapp et al., 1995) and venom from the snake Crotalus durissus terrificus (Mello and Cavalheiro, 1989) have been shown to promote neuronal injury by the destruction of neuronal axons and shrunken cell bodies. Traumatic and ischemic injury resulting in neuronal damage has long been known to be mediated by phospholipase metabolites (Bazan, 1970; Farooqui and Horrocks, 1994) . Cellular damage may have occurred as a result of arachidonic acid release as well as elevation of Ca 2ϩ levels (Kolko et al., 1996; Bazan et al., 1995) .
In addition to the identification of PLA 2 in dugite venom, a protein species with considerable sequence identity to the P. textilis short-chain ␣-neurotoxin is reported. These toxins function by binding postsynaptically to the nicotinic acetylcholine receptor, thus inhibiting propagation of nerve transmission (Tu et al., 1998) . Relative to the archetype neurotoxins such as ␣-bungarotoxin, the P. textilis neurotoxin has a lower potency (Gong et al., 1999) . The activity of the dugite neurotoxin may also exhibit a similar low level of potency.
In conclusion, this study is the first to identify the activity of PLA 2 , and the presence of a short chain ␣-neurotoxin in the venom of the Australian elapid, P. affinis. PLA 2 was found to affect tracheal smooth muscle, and is also thought to underlie the observed cortical neuron death and perturbations of cardiac myocyte beating. The successful use of cardiac myocyte and neuron cell cultures for venom research has been shown and appears to be an attractive alternative to animal experimentation for the detection of venom activities. While previous studies of dugite venom have reported the procoagulant activities responsible for incoagulable blood in human envenomation, this study has taken the first step toward identifying dugite toxins that are likely to underlie the more rare envenomation effects of cardiac arrest and paralysis. It is anticipated that a better understanding of the full spectrum of toxin activities in dugite venom will result in more advanced treatment for such snakebites.
